Sign in
4

Changes in Ownership

Xenetic Biosciences, Inc. Filed Acc 0001683168-23-008917

Options or other derivatives

  • Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mizrahy Moshe · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-06 Grant or award : show line 1 in the form Stock Options +2,500 2,500 D
Loading xslF345X05/ownership.xml…